跳至主要内容
临床试验/NL-OMON25297
NL-OMON25297已完成不适用

An open label exploratory analysis of blood, stool and the histological and immunological changes of the colonic mucosa during treatment with tofacitinib for moderate to severe ulcerative colitis

niversity Center Amsterdam (AMC)0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Subject must be at least 18 years of age.
  • 2.Males and females with a documented diagnosis of UC ≥ 4 months prior to entry into the study. A biopsy report supporting the diagnosis must be available in the source documents.

排除标准

  • 1.Presence of indeterminate colitis, microscopic colitis, ischemic colitis, infectious colitis, or clinical findings suggestive of Crohn’s disease.

研究者

发起方
niversity Center Amsterdam (AMC)

相似试验